What is the pathophysiology of dural arteriovenous fistulas and brain arteriovenous malformations?

Pathophysiology of Dural Arteriovenous Fistulas and Brain Arteriovenous Malformations

Brain Arteriovenous Malformations (AVMs)

Brain AVMs are congenital vascular malformations characterized by direct arteriovenous shunting without an intervening capillary bed, creating a pathological nidus of abnormal vessels that connects feeding arteries directly to draining veins. 1

Key Pathophysiological Features:

• Structural abnormality: AVMs consist of a tangle of abnormal vessels (the nidus) where arterial blood flows directly into veins without normal capillary resistance, creating high-flow, low-resistance shunts 2

• Hemodynamic consequences: The direct arteriovenous connection causes:

  • Increased venous pressure in draining veins
  • Potential venous ectasia and aneurysm formation
  • Rarely, vascular steal phenomena affecting surrounding brain tissue (though this is distinctly uncommon) 1

• Clinical manifestations driven by pathophysiology:

  • Hemorrhage (>50% of presentations): Results from rupture of fragile nidus vessels, feeding artery aneurysms, or venous outflow obstruction with venous hypertension 1
  • Seizures (20-25%): Caused by hemosiderin deposition, gliosis, and altered perfusion in adjacent cortex 1
  • Mass effect: From the nidus itself or associated venous congestion 3

• Natural history: Annual hemorrhage risk of 2-3% per year for unruptured AVMs, with 10-30% mortality from first hemorrhage 1

Dural Arteriovenous Fistulas (DAVFs)

Dural arteriovenous fistulas are acquired lesions consisting of abnormal arteriovenous connections within the dura mater between meningeal arteries and dural venous sinuses, bridging veins, or cortical veins—critically distinguished from AVMs by their dural location, meningeal arterial supply, and absence of a parenchymal nidus. 4, 5

Key Pathophysiological Features:

• Acquired pathogenesis: Unlike AVMs, DAVFs develop through several proposed mechanisms 4, 6, 7:

  • Venous sinus thrombosis or thrombophlebitis appears to be the primary initiating event 7
  • During thrombus organization, dural arteries normally present in sinus walls undergo pathological "growth" and angiogenesis 6, 7
  • Angiogenic factors (VEGF and related mediators) drive formation of abnormal arteriovenous communications 6
  • Ultimate fibrosis of the sinus wall and organized thrombus creates permanent shunts 7

• Triggering factors: Head trauma, prior surgery, venous sinus thrombosis, infection, or hormonal changes can precipitate DAVF formation 4, 7

• Hemodynamic patterns determine clinical behavior:

  • Benign DAVFs: Drain anterograde into dural sinuses without cortical venous reflux
  • Aggressive DAVFs: Feature cortical venous drainage (CVD), venous ectasia, or venous outflow obstruction 4, 5

• Pathophysiology of symptoms:

  • Venous hypertension with cortical venous reflux: Causes venous congestive encephalopathy, edema, hemorrhage risk 3, 8
  • Venous congestion affecting basal ganglia: Can produce Parkinsonism and dementia through metabolic dysfunction 8
  • Increased intracranial pressure: From impaired venous drainage 4

Critical Distinction Between AVMs and DAVFs:

Feature	Brain AVM	Dural AVF
Origin	Congenital	Acquired
Location	Brain parenchyma	Dura mater
Arterial supply	Pial arteries	Meningeal arteries
Nidus	Present	Absent
Pathogenesis	Developmental	Thrombosis/angiogenesis

Common pitfall: Confusing these entities leads to inappropriate treatment planning—DAVFs require assessment of venous drainage patterns (Cognard/Borden classification) while AVMs use Spetzler-Martin grading based on size, eloquence, and venous drainage 2, 4.

Both lesions share the final common pathway of abnormal arteriovenous shunting causing hemorrhage risk through venous hypertension, but their fundamentally different origins (congenital developmental anomaly versus acquired angiogenic response to venous pathology) dictate distinct natural histories and treatment approaches 4, 5.